Decision Aid for Lung Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on creating and testing a new tool to help individuals make informed decisions about lung cancer screening. It targets current and former smokers who quit less than 15 years ago and have no history of lung cancer. Participants will either use the Lung Cancer Screening Decision Aid or join a control group, allowing researchers to assess the tool's effectiveness. The trial is open to English and Spanish speakers. Those with a history of smoking who are interested in lung cancer screening options may find this trial suitable. As an unphased trial, it offers a unique opportunity to contribute to the development of a decision-making tool that could benefit many considering lung cancer screening.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this decision aid is safe for use with patients?
Research has shown that tools designed to aid decision-making about lung cancer screening can help patients make informed choices. These tools have been implemented widely to assist individuals in understanding and deciding about lung cancer screening.
Previous studies have found that patients generally find these tools easy to use. No major safety concerns exist because these tools provide information rather than physical treatments or medications. They aim to educate patients clearly and supportively about their screening options.
Moreover, professional organizations recommend these tools, confirming their safety and effectiveness in assisting patients with screening decisions. Therefore, those considering joining a trial for a lung cancer screening decision aid can feel confident about its safety.12345Why are researchers excited about this trial?
Researchers are excited about the Lung Cancer Screening Decision Aid because it aims to enhance decision-making for lung cancer screening through a more personalized and accessible approach. Unlike standard protocols that might not consider individual patient preferences and cultural differences, this decision aid is tailored for both English and Spanish speakers, making it inclusive and culturally sensitive. The trial also involves direct input from patients, families, and healthcare providers to ensure that the tool effectively addresses real-world needs, potentially leading to better-informed screening choices and improved patient outcomes.
What evidence suggests that this decision aid is effective for lung cancer screening?
Research has shown that lung cancer screening can save lives. A major study found that heavy smokers who underwent low-dose CT scans experienced 20% fewer deaths from lung cancer. In this trial, participants will use a decision aid designed to clarify the pros and cons of screening, making it easier to decide if it's right for them. Studies indicate that these aids can increase knowledge, helping patients make informed choices.16789
Who Is on the Research Team?
Robert Vok, PHD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for individuals aged 50-80 who are current smokers or quit less than 15 years ago. They must speak English or Spanish, have no history of lung cancer, and be a family member of someone with a smoking history and lung cancer.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Adaptation Phase
Cultural and linguistic adaptation of a patient decision aid video on lung cancer screening, including surveys, focus groups, and cognitive interviews
Pilot Testing Phase
Testing the adapted lung cancer screening decision aid videos to determine acceptability and impact on decision making outcomes
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Lung Cancer Screening Decision Aid
Trial Overview
The study is testing the effectiveness of a decision aid video about lung cancer screening tailored for patients in the Harris Health System. It involves surveys, focus groups, cognitive interviews, and comparison to a colon cancer screening video.
How Is the Trial Designed?
5
Treatment groups
Experimental Treatment
Placebo Group
Up to 50 participants (25 English speakers, 25 Spanish speakers)
Up to 200 physicians and other health professionals
Up to 20 participants who speak English or Spanish
Up to 40 participants who speak English or Spanish
Up to 50 participants (25 English speakers, 25 Spanish speakers)
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Citations
The quality of patient decision aids for lung cancer screening
Only 10 of the remaining decision aids met quality criteria from the International Patient Decision Aid Standards. These aids emphasized that ...
Effect of a Patient Decision Aid on Lung Cancer Screening ...
The National Lung Screening Trial found 20% fewer lung cancer deaths among current and former heavy smokers screened using low-dose computed ...
Shared Decision-Making for Lung Cancer Screening
Most studies reported on knowledge; few addressed clinical and patient-centered outcomes. Specific SDM tool choice may not impact LCS. A ...
Lung cancer screening completion among patients using ...
This alarming statistic underscores the importance of annual lung cancer screening (LCS), which has been shown to reduce mortality by 20% [2].
5.
research.va.gov
research.va.gov/research_in_action/Tools-to-aid-decision-making-for-lung-cancer-screening.cfmTools to aid decision-making for lung cancer screening
A tool to help patients and their health care providers weigh the risks and benefits of lung cancer screening.
Lung Cancer Screening Decision guide
You may be eligible for lung cancer screening if: You are between 50-80 years old, and;. You currently smoke cigarettes or quit smoking within 15 years, and;.
Should I Screen: Lung cancer screening decision aid
Lung Cancer Risk Calculator. Do you want to know if you should be screened? Use our calculator to see your personalized lung cancer risk. Use it →. Share ...
Lung Cancer Screening Benefits and Harms Stratified ...
The NLST randomized 53,452 persons at high risk for lung cancer on the basis of age and smoking history to either a low-dose CT scan or chest radiography (2).
P1.03-055 LuCaS DA: A Lung Cancer Screening Decision ...
We report preliminary results of a web-based interactive LC decision aid (LuCaS DA) on LC screening knowledge and decision making.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.